2011
DOI: 10.1016/j.bbrc.2011.03.140
|View full text |Cite
|
Sign up to set email alerts
|

Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
42
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(46 citation statements)
references
References 31 publications
4
42
0
Order By: Relevance
“…We initially showed that inhibition of Fyn either by siRNA or by miR-125a-3p led to a decrease in the proliferation of HEK 293T cells and to their arrest at the G2/M phase of the cell cycle. These findings are in agreement with lines of evidence indicating the role of SFKs in cell proliferation and in the G2/M transition of the cell cycle (Zhao et al, 2011;Arai et al, 2012;Hitosugi et al, 2007) as well as with the finding that SU6656, an SFK inhibitor, induces a defective cleavage of mouse oocyte (Levi et al, 2010) and a defective cleavage furrow formation in synovial sarcoma cells, resulting in their arrest at the G2/M phase and their subsequent apoptosis (Arai et al, 2012). Furthermore, inhibition of Fyn by microinjection of dominant-negative Fyn into mouse oocytes caused inhibition of the second polar body extrusion and of the first mitotic cleavage (Levi et al, 2011;Gallo et al, 2012).…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…We initially showed that inhibition of Fyn either by siRNA or by miR-125a-3p led to a decrease in the proliferation of HEK 293T cells and to their arrest at the G2/M phase of the cell cycle. These findings are in agreement with lines of evidence indicating the role of SFKs in cell proliferation and in the G2/M transition of the cell cycle (Zhao et al, 2011;Arai et al, 2012;Hitosugi et al, 2007) as well as with the finding that SU6656, an SFK inhibitor, induces a defective cleavage of mouse oocyte (Levi et al, 2010) and a defective cleavage furrow formation in synovial sarcoma cells, resulting in their arrest at the G2/M phase and their subsequent apoptosis (Arai et al, 2012). Furthermore, inhibition of Fyn by microinjection of dominant-negative Fyn into mouse oocytes caused inhibition of the second polar body extrusion and of the first mitotic cleavage (Levi et al, 2011;Gallo et al, 2012).…”
Section: Discussionsupporting
confidence: 93%
“…To assess the feasibility of the use of miR-125a-3p as a regulator of Fyn expression in various cancerous cells, we examined the expression of Fyn mRNA in miR-125a-3p-overexpressing cancer cell lines: MNT-1 (melanoma cancer), U2OS (osteosarcoma), MDA-MB-231, MCF-7 and SKBR3 (breast cancers), PC3 (prostate cancer) and HeLa (cervical cancer). The role of Fyn in tumor progression or its overexpression has already been illustrated in these cancer cell lines, with the exception of osteosarcoma (Teutschbein et al, 2009;Huang et al, 2003;Zhao et al, 2011;Posadas et al, 2009;Bilal et al, 2010;Yadav and Denning, 2011). We found that the expression of Fyn mRNA was reduced in all the examined cell lines, except HeLa cells (Fig.…”
Section: Mir-125a-3p Negatively Regulates the Activity Of Proteins Dosupporting
confidence: 70%
See 1 more Smart Citation
“…NDRG1 is a cytoplasmic protein involved in stress responses, hormone responses, cell growth, and differentiation (35,36). Studies demonstrated that NDRG1 expression was decreased in cancer primary and metastatic cells when compared to normal cells and was thought to function as a metastasis suppressor in cancer types including ovarian, colon, and prostate cancers (37)(38)(39). NDRG1 has also been reported to be necessary for p53-mediated apoptosis and it plays a role in suppressing malignant cell growth (40).…”
Section: Discussionmentioning
confidence: 99%
“…[22][23][24][25] Cells were cultured in Dulbecco's modified Eagle's medium (Gibco, NY, USA) supplemented with 10% fetal bovine serum (Gibco), in a humidified atmosphere containing 5% CO 2 at 37 C. Hypoxic conditions were created using a hypoxia chamber contained 1% O 2 , 5% CO 2 , and balanced with N 2 or using CoCl 2 to produce hypoxic conditions. CoCl 2 , YC-1, DiI, DAPI, and Alexa Fluor 594-labeled phalloidin were purchased from Sigma-Aldrich (St Louis, MI, USA).…”
Section: Cell Culture and Materialsmentioning
confidence: 99%